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 Inhibitors of cAMP phosphodiestereses (PDEs) promoted an increase in 
intracellular [cAMP]c and an influx of Ca2+, in both MMQ pituitary cells and α-
Pancreatic cells. The specific targets for PDEs and the domains of PDEs are still 
unknown. Pituitary MMQ cells were used as a model to test modulation of calcium influx 
through the L-type calcium channel with PDE inhibitors. cAMP analogs were used to 
determine cAMP molecular targets. 8-cpt-cAMP initiated an Epac mediated pathway and 
had strong effects on calcium influx in the cell; suggesting, a relatively strong cAMP 
target. Experiments of α-Pancreatic cells were done in 2mM glucose and 8mM glucose to 
stimulate hypoglycemia and resting states respectively. Ca2+ induced Ca2+ release (CICR) 
was observed when αMSH was applied with the three PDE inhibitors. When αMSH was 
applied without a PDE inhibitor there was no increase in [cAMP]c, suggesting a micro 
domain.  Extracellular solutions of 2mM glucose with PDE inhibitors such as Milironone, 
there was influx through N-type and L-type channels and then steady CICR. Rolipram 
decreased the amount of [Ca2+]c influx compared to the control, suggesting an inhibitory 
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Peptide hormones are chemical signals that are released from endocrine cells in a 
tightly regulated manner. After secretion, the hormone, travelling through the 
bloodstream will bind to a specific protein receptor on the target cell and cause a signal 
transduction specific to that cell type. Such hormonal signals regulate many functions of 
the body such as heart rate, mood and metabolism. Peptide hormone synthesis begins 
with the translation of messenger RNA. The N-terminal signal peptide directs the 
growing amino acid sequence to the rough endoplasmic reticulum where translation 
continues through “docking proteins.” The protein is typically translated as a prohormone 
that undergoes further processing in the Golgi-apparatus. Final cleavage of the 
prohormone into the bioactive peptide occurs within the granules that will contain the 
hormone (Berne et al, 1998). Protein hormone processing also includes concentration of 
hormone into large Dense Core Vesicles (DCV) and later exits the cell through regulated 
exocytosis (Dannies, 1999). The exocytosis of DCV and secretion of hormone is tightly 
controlled by both Ca2+ and cyclic adenosine monophosphate (cAMP) signaling 
pathways within the endocrine cells.  
Exocytosis of Dense Core Vesicles is highly regulated 
 In order for the DCV to fuse with the plasma membrane an extracellular stimulus 
triggers a rise in cytosolic Ca2+ that initiates exocytosis of the vesicle to the plasma 
membrane. Exocytosis is likely due to the activity of the Ca2+-binding protein 
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synaptotagmin (Tao Hu et. al, 2008). Resting cytoplasmic [Ca2+] is near 100nM, and 
extracellular concentrations are around milimolar ranges (Bergner et al., 2008). In 
addition to the rise in intracellular Ca2+ concentrations that triggers exocytosis, other 
signals may control secretion such as the GTP binding proteins, control of microtubule 
and microfilament dynamics and a rise in cAMP, all of which may control the movement 
of the vesicles to the plasma membrane for exocytosis (Berne et al., 1998).  These 
intracellular signaling pathways can become quite complex since cross-talk between the 
pathways may exist in some cell types. The primary focus of this thesis is the potential 
cross-talk between Ca2+ and cAMP pathways in endocrine cells.  
Control of Intracellular [Ca2+]  
For various endocrine or neuroendocrine cell types there are different mechanisms 
for increasing cytosolic [Ca2+] in order to stimulate DCV release. In all instances it is the 
concentration of Ca2+ in the cytoplasm ([Ca2+]i) that is relevant for exocytosis. Calcium 
can enter the cytoplasm from the extracellular space via voltage-gated calcium channels 
or it can be released from intracellular stores.  
All endocrine cells use voltage-gated Ca2+ channels to control [Ca2+]i.   Each cell 
type will have its own unique primary signaling event that will lead to depolarization of 
the plasma membrane and opening of voltage-gated Ca2+ channels. The resulting Ca2+ 
influx is often sufficient to drive exocytosis of DCV and secretion of hormone. 
The main source of intracellular Ca2+ release comes from the endoplasmic 
reticulum. The Ca2+ concentration in the ER is regulated by the smooth endoplasmic 
reticulum Ca2+ ATPase (SERCA), which can pump Ca2+ into the ER. Ca2+ release from 
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the ER into the cytosol is initiated by opening of either the inositol-1,4,5-phosphate-
receptor (IP3R) or the ryanodine-receptor (RyR).  IP3R is made up of 4 subunits upon 
which IP3 can bind. Cytoplasmic calcium can regulate the sensitivity between the receptor 
and its ligand (IP3) and Ca2+ binding proteins can activate the IP3R. In skeletal muscle, 
the RyR receptor is opened by a unique mechanical coupling with the plasma membrane 
but for all other cell types Ca2+ binding proteins can open the RyR. Therefore the RyR is 
opened by an increase in cytoplasmic Ca2+. In addition, there are other molecules such as 
cyclic ADP-Ribose that can influence RyR opening. For both the IP3R and RyR an 
increase in cytoplasmic Ca2+, due to Ca2+ influx, can trigger the release of calcium from 
stores within the ER. This process is called Ca2+-induced Ca2+-release (CICR). In some 
endocrine cells, initial Ca2+ influx through voltage-gated Ca2+ channels triggers CICR 
within the cell that will initiate more secretion of hormone from exocytotic vesicles than 
would Ca2+ influx alone (Bergner et al., 2008).  
cAMP Pathway: Adenyl Cyclase 
 The adenylyl cyclase-cAMP pathway is a ubiquitous second messenger system in 
eukaryotes. The plasma membrane enzyme, adenylyl cyclase is a highly regulated 
enzyme that catalyzes the formation of cAMP from ATP and the cofactor Mg++.  The 
resulting cAMP then activates other signaling proteins. The common mechanism for 
activation of adenylyl cyclase is via the stimulatory G protein (Gαs), which increases 
intracellular cAMP levels via the allosteric activation of adenylyl cyclase. Gαs itself is 
controlled by the activation of specific G protein coupled receptors (GPCRs) that respond 
to an array of ligands with high specificity. Some forms of adenyl cyclase can be 
inhibited by the inhibitory G protein (Gαi). Gαi is also activated by specific GPCR, 
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activation of Gαi decreases the amount of cAMP in the cell. G-proteins such as Gαs and 
Gαi are made up of the α, β, and γ subunits and have GDP bound to the a subunit during 
resting states. Binding of the ligand to its GPCR causes a conformational change in the 
receptor, which triggers the dissociation of GDP from the α subunit and binding of GTP 
to the α subunit instead. The disassociation of the α subunit, bound to GTP, from the β, 
and γ subunit officially activates this protein complex (Dorsam and Gutkind, 2007).   
Depending on which α subunit that is bound to GTP can either stimulate or inhibit cAMP 
production by downstream affects.  
 Molecular cloning has shown there are 9 mammalian genes that encode for 
membrane bound adenylyl cyclase and one gene produces a soluble isoform. While all 
adenylyl cyclase membrane bound isoforms can be activated by Gαs only a subset of 
these are subject to regulation by Gαi .In addition to regulation by these G proteins, some 
isoforms are subject to allosteric regulation by Ca2+ binding proteins. Specifically, AC5 
and AC6 are two isoforms that are inhibited by Ca2+. Most isoforms of AC will be 
inhibited with calcium in the milimolar range (non-physiological), but the AC5 and AC6 
isoforms that are inhibited in the µM range.  In addition to inhibition by Ca2+ of some 
forms of adenyl cyclase, other forms can be activated by Ca2+ as well.  AC3 is potently 
activated by an increase in Ca2+, this activation is comparable to Gαs activation. Ca2+ can 
therefore regulate [cAMP]c via control of adenyl cyclase in some cells types and cross-
talk between Ca2+ and cAMP signaling molecules can be physiologically important for 
specific cell types (Steer, 1975). For example, it is thought that the entry of calcium 
through voltage-gated channels is the sole source of calcium to inhibit the AC5 and AC6 
(Sunahara and Taussig, 2002). 
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cAMP Pathway: cAMP Phosphodiesterases  
cAMP Phosphodiesterases (PDE) are enzymes that break down cAMP by 
hydrolysis to the biologically inert 5’-AMP (Berne et. al, 1998).  There are over 15 cyclic 
nucleotide phosphodiesterase genes in mammals, and 12 are highly selective for cAMP 
(Conti et. al, 2002). Many of these genes are subject to extensive alternative splicing with 
the splice variants showing very distinct properties.  Well over 20 cAMP PDE isoforms 
exist.  While all isoforms share a common PDE activity they are widely varied in term of 
cell type expression patterns and sub-cellular localization with cells. In addition they are 
each subject to an array of physiological regulation. Some PDEs have allosteric cAMP 
binding sites (distinct from the active site) that serve as points of allosteric activation or 
inhibition, thus working as a negative feedback or feed-forward loops (depending on 
isoform) when concentrations of cAMP get high within the cell. Ca2+ activates other PDE 
isoforms such as PDE3.  Thus PDEs have the potential to be another point of cross-talk 
between Ca2+ and cAMP signaling cascades.  
All PDEs can be inhibited by xanthine derivative IBMX (3-isobutyl-1-
metylxanthine) or high concentrations of caffeine. However, there is sufficient 
divergence in the active site of selective inhibitors of different PDEs that have been 
investigated (Beavo, 1995).   This property of PDEs has made them a highly sought after 
target for pharmaceutical companies.  cAMP signaling occurs in essentially all cell types 
in humans. Tissue selective targeting of cAMP signaling could control many diseases.  
There are no isoform-selective adenyl cyclase inhibitors, so pharmaceutical manipulation 
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of AC is not a possibility. However the isoform specific PDE inhibitors, together with the 
cell-type specific expression of different PDEs make them a viable drug target. In fact 
some PDE inhibitors are already used as approved pharmaceutical drugs (Shim et. al, 
2001). These isoform specific PDE inhibitors are also quite valuable for experimental 
study of a cell of interest. For example, inhibition of PDE3 with Milironone resulted in an 
increase in basal calcium in human atrial myocytes. Similarly, Ro20-1724 or Rolipram, 
two selective PDE4 inhibitors, enhanced the response of the L-type calcium channel to 
cAMP (Verde et al, 1999). These PDE inhibitors together with the broad spectrum IBMX 
were used in this thesis to study the cross talk between cAMP and Ca2+ signaling in 
endocrine cells. 
cAMP Pathway : target proteins PKA & Epac  
cAMP has been recognized as an intracellular signaling molecule for nearly 40 
years.  Initial studies indicated that cAMP could control protein phosphorylation. It is 
now recognized that this occurs via the cAMP regulated protein kinase (PKA). PKA 
exists as a tetramer of two cataylitc (C) subunits and two cAMP-binding regulator (R) 
subunits, each with two cAMP binding sites. Upon the cooperative binding of 4 
molecules of cAMP to the inactive complex, the catalytic subunits dissociate and are free 
to phosphorylate target proteins.  The specific targeting of PKA to anchoring proteins 
called AKAPs result in highly localized cAMP-dependent phosphorylation. It is 
noteworthy that PDE4 can also be anchored to some AKAPs. 
 PKA-dependent phosphorylation can account for many or even most cAMP-
dependent signaling within cells. However, it was long recognized that “PKA-
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independent”, but cAMP-dependent signaling can occur, suggesting the presence of 
another cAMP-binding protein in intracellular signaling. Epac is such a protein that has 
been identified within the last 10 years. While much less is known regarding Epac 
signaling it is beginning to be recognized to control a range of cellular processes. In 
mammals, two isoforms of Epac exist, Epac1 and Epac2, the number of cAMP-binding 
domains on the isoforms designates them. Epac is a guanine nucleotide exchange factor 
that stimulates the exchange of GDP for GTP on the small GTPases, Rap1 and Rap2. The 
ability of EPAC to act as an exchange factor is dependent upon cAMP binding.  While 
Rap1/2 were the first identified targets of Epacs, it now appears that Epac confers cAMP 
sensitivity to other proteins. 
Cross-talk between cAMP and Ca2+ signaling pathways 
Both cAMP and Ca2+ are recognized as ubiquitous second messenger systems in 
all eukaryotic cells. In endocrine cells, as well as other cell types, it is likely that there is 
significant cross-talk between these second messenger systems. Cross talk refers the 
ability of a signaling module in one of the pathways to influence the other pathway. For 
example, direct regulation of adenylyl cyclase or PDE by Ca2+ would represent such 
cross talk. Similarly, PKA-dependent phosphorylation of a voltage-gated Ca2+ channel 
resulting in stronger Ca2+ influx or Epac modulation of Ca2+ store release would also 
represent cross talk. Such cross talk mechanisms likely provide for the highly regulated 
nature of hormone secretion. This thesis focused on potential cross talk in the pancreatic 
alpha cells of the endocrine pancreas.  Studies were also conducted with pituitary 
lactotrophs for comparison. 
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Anatomy of the Pancreas  
Regulation of blood glucose levels is the primary function of the endocrine 
pancreas. Pancreatic β cells release insulin in response to high glucose and pancreatic α- 
cells release glucagon when blood sugar is too low. These endocrine cells are located 
within the islets of Langerhans, which are a group a few hundred to ~1000 endocrine 
cells and are comprised of different endocrine cell types. The majority (70 to 80 %) of the 
cells in an islet are insulin-secreting beta cells, which are in the core of the islet and then 
surrounded by alpha cells that secrete glucagon. Smaller numbers of delta cells secrete 
somatostatin and PP cells secrete pancreatic polypeptide. Extensive studies on pancreatic 
beta cells have elucidated the mechanisms by which high glucose in the blood triggers 
Ca2+ influx and insulin secretion from beta cells. However, in comparison, very little is 
understood about pancreatic alpha cells. For example it is not even clear how signals 
trigger glucagon secretion.  
It is the role of insulin, as a peptide hormone, to decrease blood glucose 
concentration, during a time of hyperglycemia (blood glucose > 180mg/dL). Insulin 
triggers peripheral glucose uptake and storage into livers. Blood glucose levels can 
decrease to below normal levels (blood glucose 70-110mg/dL), resulting in 
hypoglycemia (blood glucose < 70mg/dL). Hypoglycemia triggers the release of 
glucagon from the alpha cells. The release of glucagon allows for glucose to be released 
from cellular stores in the liver. Type I diabetes is characteristic of an auto-immune 
disease in which the body destroys the beta-cells that produce insulin, and the body 
becomes depleted of insulin injection to store glucose. Type II diabetes develops when 
the body becomes resistant to insulin or the pancreas stops properly secreting sufficient 
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insulin. Both conditions result in too much circulating glucose in the blood and will 
become detrimental to other organs. This central role of insulin and beta cells in diabetes 
has led to a very good understanding of the functional control of insulin secretion. 
Pancreatic β-cell Physiology 
Numerous studies have been done to confirm the physiological pathway in which 
insulin is released from pancreatic β-cells. Glucose directly stimulates the beta cells and 
leads to an increase in cytoplasmic Ca2+ and insulin secretion. It is the transport of 
glucose into the cell through the GLUT-2 transporter (a βcell –specific transporter) that 
initiates the process of glycolysis within the cell. Glycolysis starts in the cytosol of the 
cell and continues through the Krebs cycle in the mitochondrial matrix. Throughout this 
process the production of energy containing elements such as NADH and FADH2 are 
created along with ATP. It is the final process, the electron transport chain that uses O2 as 
the final electron acceptor and presents the cell with the majority of ATP. As glucose 
increases within the blood, more glucose will be transported through GLUT-2, glycolysis 
increases, and an abundance of ATP is produced inside the cell. An increase of ATP in 
the cytosol of the beta-cell will shut down the K+/ATPase channel. The shutting down of 
the K+/ATPase will depolarize  the plasma membrane and cause the opening of the L-
type calcium channel in the plasma membrane resulting in influx of calcium (Mears, 
2004). It is the role of intracellular increase in calcium to trigger release of insulin.  
The GLUT2-KATP -Ca2+ influx pathway is the primary signaling pathway for 
insulin secretion and is sufficient to trigger insulin release. In addition, other pathways 
can enhance glucose-dependent insulin release. Numerous gut hormones, also known as 
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incretin’s are responsible for increasing the cellular concentration of cAMP in beta cells. 
cAMP potentiates glucose-induced insulin secretion in beta cells through a number of 
mechanisms including, increased opening of voltage gated calcium channels, calcium-
induced calcium release, activation of ryanodine receptors in the ER and direct effects on 
exocytosis (Pyne, 2003).  While Ca2+ is the trigger for insulin secretion, cAMP can 
stimulate exocytosis in beta-cells by PKA-dependent and independent pathways. PKA 
can phosphorylate L-type Ca2+ channels and increase Ca2+ influx. The PKA-independent 
process involves cAMP-guanidine nucleotide exchange factor II (GEFII) which, interacts 
with the Rab protein and interacting molecule Rim2. Rim2 is involved in vesicle priming 
and has been shown to interact with protein receptor proteins such as SNAP-25 and 
synaptobrevin so that granules make it to the plasma membrane (Ma et al, 2004).  
Pancreatic α-cell physiology 
To increase blood glucose, glucagon, released from alpha cells, initiates liver 
glucose output by stimulating glycogenolyisis and gluconeogenesis and decreasing 
glycolysis and glycogenesis (Gromada et al, 2007). While it is clear that alpha cells 
release glucagon when blood glucose is low, the mechanisms for control of glucagon 
secretion are much less well understood than is beta cell release of insulin. It is 
apparently quite complex as alpha cells release glucagon by metabolic and hormonal 
signals. Epinephrine, glucose-dependent insulinotropic polypeptide (GIP) and 
extracellular glucose are all examples of possible initiators of glucagon release. 
Epinephrine binds to the β-adrenergic receptor of the α-cell, this will increase cAMP and 
protein kinase-A enhancement. Incretin hormones such as GLP-1 and GIP stimulate 
exocytosis in a PKA-dependent pathway.  Paracrine inhibittion of glucagon release 
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comes from insulin, Zn2+ (which is secreted with insulin), γ-amino butyric acid (GABA), 
and somatostatin (Olsen et al, 2005). Insulin receptors are widely expressed in alpha 
TC1-6 cells and glucagon secretion will be inhibited by insulin binding to the alpha cell. 
Insulin binding to a receptor on the alpha cell will inhibit electrical activity and glucagon 
secretion by activation of the K+/ATPase channel, which causes cellular 
hyperpolarization.  
Alpha cells generate spontaneous Na+ and Ca2+ action potentials, which means 
they are electrically excitable. Na+ and Ca2+ are the reason for action potentials whereas 
K+ currents are used to repolarize the cell. Alpha cells express N-type Ca2+ channels, R-
type calcium channels, T-type calcium channel, L-type voltage gated calcium channels as 
well as a Na+ channels. N-type and L-type Ca2+ channels have been the most notably 
important channel for glucagon release during times of low blood glucose. L-Type Ca2+ 
channels are potentiated by cAMP and PKA pathways (Gromada et al, 2007).  
PKA will be activated through increased levels of cAMP from stimulatory G- 
proteins and it’s the job of PKA to increase the mean probability to open individual Ca2+ 
channels, more specifically L-type calcium channels (Verde, et. al, 1999). A separate 
cAMP process is initiated with GLP-1 (glucagon-like-peptide) binding to its appropriate 
receptor and Epac can mediate cAMP’s stimulation. Rap1 is active in the GTP-bound 
state and inactive in the GDP-state, it is the activation of Rap 1 and Epac that stimulates 
Ca2+ -induced Ca2+ -release from the ER. GLP-1 stimulation can work through Epac and 
a PKA pathway. The PKA pathway will induce IP3R sensitivity and GLP-1 stimulation of 
Epac works to make RyR sensitive to Ca2+ triggering for Ca2+ release (Holz, 2004).  
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Further studies have shown that Epac interacts closely with the K+/ATPase 
channel. There is evidence that Epac -selective cAMP analogues are able to shut down 
the activity of the K+/ATPase channel (Kang et. al, 2006).  
Alpha cells also can respond directly to lowering of extracellular glucose. Alpha 
cells contain the same type of ATP-sensitive K+ channel as β-cells and the inactivation of 
the channel will cause DCV release. Low glucose in alpha cells trigger spontaneous 
action potentials Ca2+ influx and glucagon secretion (Olsen et al., 2005).  At low glucose 
concentrations the K+ channel is open but alpha cells have a high ATP ratio in the cell so 
it doesn’t take much initiation of glycolysis of glucose to shut the K+/ATP channel and 
cause DCV release.  
The melanocortin α-MSH appears to be an essential primary signal for glucagon 
secretion. Deletion of the POMC gene that encodes α-MSH abolishes glucagon secretion 
in mice (Brennan et al. 2003). Recent studies in the Angleson lab have demonstrated that 
alpha cells express the α-MSH receptor MC4R, and that activation of MC4R leads to 
production of cAMP and results in CICR and ultimately glucagon secretion (Lumsden 
MS thesis; Liang MS thesis, Imseis MS thesis). How MC4R-induced cAMP controls 
CICR is not yet resolved. 
Exocytosis of glucagon ultimately requires increasing intercellular Ca2+, however 
one mechanisms of cellular activation of glucagon secretion uses receptors such as 
MC4R that increase initially cAMP, this cAMP signal then leads to an increase in Ca2+. 
There is also the possibility that hypoglycemia directly triggers Ca2+ influx (through 
control of membrane potential) and that cAMP signals may amplify the hypoglycemia 
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induced signal. It is the objective of this thesis to investigate the cross-talk between Ca2+ 
and cAMP for glucagon secretion in response to both MCR4 activation and 
hypoglycemia. 
Lactotroph Signaling  
 In addition to the primary focus on Ca2+ and cAMP signaling in alpha cells, this 
study also investigated signaling in pituitary lactotrophs cells. These are a neuroendocrine 
cell type known to respond to changes in membrane potential to trigger Ca2+ influx and 
hormone secretion and in which cAMP, while not a primary signal, can amplify Ca2+ 
influx and hormone secretion. In this study the MMQ lactotroph cell line was used to 
compare and guide the understanding surrounding cAMP and Ca2+ influx. Lactotrophs 
respond to an array of signals including dopamine, estrogen, progesterone and 
VIP/PACAP. Previous studies have demonstrated dopamine to have an inhibitory effect 
on calcium influx into cell and DCV release of prolactin. MMQ cells use voltage-gated 
channels as their sole source of Ca2+ influx into the cell. In the absence of dopamine, 
MMQ cells show spontaneous excitability, Ca2+ influx and a moderate level of hormone 
secretion. This basal level of Ca2+-dependent exocytosis can be amplified by activation of 
G-protein coupled receptors that link to Gαs and triggering of cAMP production. cAMP-
activation of PKA is thought to potentiate calcium influx through voltage gated calcium 
channels. For this study MMQ cells serve as model cell where cAMP acts as a potentiator 
of calcium influx through voltage-gated channels. By understanding the workings of 
calcium influx and cAMP interactions we can better understand the workings involved in 
endocrine cells in general and hopefully provide comparison to alpha cells. 
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Objective of study 
 This study looks into the interactions of calcium and cAMP in stimulation of 
endocrine cells.  The primary motivation is to begin to understand the intracellular signals 
in alpha cells that control glucagon secretion.  Based on previous studies in the lab of the 
clonal alpha TC1-6 cells, α-MSH activates cAMP production and cAMP can trigger 
CICR. In this scenario, a primary signal first leads to cAMP and this then leads to the 
necessary increase in Ca2+. In addition, alphaTC1-6 cells show strong CICR in direct 
response to hypoglycemia, it is unknown if Ca2+ and cAMP interact under these 
conditions. In order to investigate cAMP modulation of Ca2+ influx, I also studied MMQ 
lactotroph cells. These studies employed Fura2 imaging of intracellular Ca2+ and 
CFP/YFP Fret-cAMP reporter for time resolved analysis of cAMP analysis. The results 
revealed many potential points of Ca2+-cAMP interaction that involved both PKA and 
Epac as cAMP targets. The studies also point to PDE3 and PDE4 as being major 





   
 
 










Figure 1: Alpha Cell Glucagon Secretion 
 Specific interactions in alpha cells include cAMP and Ca2+ regulation for 
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MATERIALS AND METHODS 
 
Cell Culture 
 Mouse pancreatic α cell line αTC1-6 cells (received from D. Steiner, 
University of Chicago) were grown in DMEM containing 15mM glucose, 10% heat 
inactivated fetal bovine serum, 1.0mM sodium pyruvate, 100unit/ml penicillin, 100µg/ml 
streptomycin, 100µg/ml normacin, and MEM non essential amino acids, and maintained 
in a humidified incubator with 95% air and 5% CO2 at 37°C.  
MMQ cells obtained from ATTC were cultured in F12K media with 15% horse 
serum and 2.5% fetal bovine serum 100unit/ml penicillin, 100µg/ml streptomycin, 
100µg/ml normacin in a humidified incubator with 95% air and 5% CO2 at 37°C. The 
standard external solution used contained 140mM NaCl, 1mM MgCl2, 2mM KCl, 5mM 
CaCl2, 10mM D-Glucose and 10mM HEPES, with a pH of 7.2.  The high K+ external 
solution was the same, but contained 100mM KCl and 42mM NaCl.   
Intracellular Ca2+ Imaging 
Fura-2 is a ratiometric calcium indicator, It is loaded into cells as the membrane 
permeant Fura-2AM loaded at room temperature for 30 minutes in a resting standard 
extracellular solution containing, For alphaTC1-6 cells this was: 1.0mM MgCl2, 10.0mM 
HEPES, 5.0mM CaCl2, 140mM NaCl2, 2.0mM KCl, 8.0mM D-glucose, and pH adjusted 
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to 7.2.  For MMQ cells it was: 140mM NaCl, 1mM MgCl2, 2mM KCl, 5mM CaCl2, 
10mM D-Glucose and 10mM HEPES,  pH 7.2.    
Alpha cell were plated 48hrs prior to imaging on ECL-coated imaging chambers. 
ECL is placed on 12mm glass bottom dishes for 1hr, then adherent cells are plated on 
glass bottoms with growth media and placed in incubator for 48 hours day. Upon 
imaging, Growth media is removed and is replaced with standard extracellular (500µl) 
solution and 2.5µl Fura-2 (50 mM stock in DMSO) for 30minutes at room temperature, 
then imaged. MMQ cells were plated with ECL on the day of imaging and fura solution 
was placed on the cells for 30min. After 30minutes, the glass dishes are washed 3 times 
with fresh standard extracellular solution.  
For both cell types experiments were conducted at ambient temperature (~22 C). 
Images were acquired by 40X oil immersion objective (Zeiss) with an inverted 
fluorescence Zeiss Axiovert microscope equipped with Cooke SensiCam CCD camera. 
340nm and 380nm excitation filters controlled by a Sutter lamda 10-2 filter wheel were 
used for Fura-2 dual excitation ratio imaging. Image pairs were obtained every 3 seconds 
and binned with either a setting of 4x4 or 2x2, chosen to maximize signal while avoiding 
camera saturation. Images were acquired and analyzed with the Slidebook software. 
Perfusions of the indicated test external solutions were performed using a gravity flow 
system with an insert that provides uniform solution flow. Suction was located on the 
opposite of the plate to allow for solution changes.  
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Nucleofection of cells 
 cAMP imaging employed transient expression of the CFP-YFP FRET reporter 
plasmid H84(REF). Plasmid was incorporated into MMQ and αTC1-6  via nucleofection 
(Amaxa-Lonza). 1.5 mg of endotoxin-free purified plasmid DNA in 100µl solution of L 
for each reaction with setting A20, using Cell Line Nucleofector Kit (Amaxa Inc). 48hrs 
prior to imaging, glass bottom plates (12mm) are coated with ECL for 1hr prior to plating 
of transfected cells. After ECL is removed the plates are loaded with 200µl of fresh warm 
media into the viewing window of the plate. Appropriate external solutions are warmed 
in a water bath at 37°C. 1.2x106 αTC1-6 and MMQ cells are counted out for each 
reaction, yielding 3 plates per reaction. After transfection, cells recoverd in humidified 
incubator for 2hrs to settle onto plates, after 2hrs 2ml of warm fresh media is added. Cells 
recover for 2 days before imaging. 
cAMP-FRET measurements 
48hrs after transfection, cells are imaged using inverted fluorescence microscope 
with 40X oil immersion objective, and excited at 425nm (CFP, FRET Donor excitation) 
and Emission of CFP and YFP was detected through 470nm and 530nm filters. Cells 
were perfused with indicated extracellular test solutions and suction is used on the 
opposite of the dish. Images are captured at 3-second intervals at a bin factor of 4x4. 
Flourescence resonance energy transfer (FRET) was expressed as a fluorescent intensity 
of CFP/YFP emission ratio. The reporter consists of a cAMP binding domain linking 
CFP and YFP. In the absence of cAMP, the protein fold to allow energry transfer 
between CFP and YFP, as cAMP binds the reporter, it induces a rapid conformational 
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change that disrupts FRET. This results in fluorescent emission of CFP increase while 
YFP decreases, overall this increases the ratio between CFP and YFP. Data indicates 
overall [cAMP] levels.  
MMQ cAMP biochemical assay 
 To test cAMP production biochemically in populations of MMQ  cells a cAMP 
EIA assay was used (Assay Designs). Cells are placed into with indicated test solution for 
30min at room temperature. At the end of the 30 minutes the reactions were quenched 
and frozen at -20 fridge for subsequent analysis of cAMP content.  
Reaction material was thawed and then washed with buffered saline solution. 
cAMP standards were made by setting up 5 test tubes and adding 900µl of 0.1M HCL to 
test tube 1 and 750µl of 0.1HCL to test tubes 2-5. Take 250µl out of test tube 1 and add it 
to test tube 2, while taking 250µl from test tube 2 and adding it to test tube 3 and so on 
until all 5 test tubes have the same amount of liquid. 50µl of neutrilizer is added to all 
desired wells except TA and blank. 100µl of HCL is added to Bo wells and NSB, as well 
as 50µl of HCL to NSB. 100µl of each standard is added into appropriate wells of 
standard 1-5. 100µl supernatant from thawed cells is added into appropriate wells. 50µl 
of blue conjugate is added into every well except TA and blanks. 50µl of yellow antibody 
for cAMP goes in every well except NSB, blank and TA. 96 well plate sits on shaker for 
2hours at 300rpm at room temperature. After appropriate 2hr spin, the wells are washed 
with 400µl of wash buffer 3 times. 5µl of blue conjugate is added into the  TA wells as 
well as  200µl of substrate solution goes into every well. 96 well plate sits in room 
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temperature for 1hr and then is read for absorbance using a Biotek Synergy HT Plate 
reader.  
Graphical Analysis 
 Images from Fura2 or cAMP FRET microscopy experiments were analyzed in 
Slidebook (Intelligent Imaging Innovations, Denver CO). Values were exported as ASCII 
files and imported in Igor software (Wavemetrics). Traces of ratio values for Fura2 or 
cAMP-FRET imaging were analyzed and graphed in Igor. Statistical using unpaired 
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Table 1: Drugs used in MMQ cells and Alpha cells  
 Brief description of drugs pertaining to experimental procedures. 








levels of cAMP 
50µM (1:200) 10mM DMSO 
IBMX Non-selective 
PDE inhibitor 
1µl (1:500) 500mM  DMSO 
8-CPT-2’-O-
Me cAMP 
Epac activator 50µM 
20µM 
50mM water 
6-Benz cAMP PKA activator 20µM 10mM water 
Rolipram PDE4 inhibitor (1:2000) 10µm 20mM DMSO 
Milironone PDE3 inhibitor (1:2360) 10µm 23.6mM DMSO 
Fura-2 AM Calcium 
indicator dye 










300nM (1:390) 117µM water 
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Table 2: Abbreviated Nomenclature 










methyladenosine- 3',5'-cycli c 
monophosphate sodium salt 
 
8 –CPT-2’-O-Me cAMP biolog 
N6-Benzoyladenosine-3′,5′-cyclic 
monophosphate sodium salt 
 
6-Benz cAMP calbiotech 
Vasoactive intestinal polypeptide  
 
VIP 
























cAMP effects on Ca2+ influx in MMQ lactotrophs 
The first series of experiments was directed at analyzing cAMP potentiation of 
Ca2+ influx in resting MMQ lactotrophs. In the absence of any input, our resting 
conditions, lactotroph cells are known to have spontaneous action potentials and sporadic 
Ca2+ influx (Stojilkovic, 1992). I tested whether physiological or pharmacological 
elevation of [cAMP] would alter Ca2+ influx under these conditions. 
[cAMP] in resting MMQ cells 
 The first experiments assessed [cAMP] in resting MMQ cells. With the use of 
Fret-analysis, [cAMP]c levels are ratiometrically plotted as a graph of levels of [cAMP]c 
versus time (s). The experiment begins with cells in the standard resting solution, (5K+), 
then switched to 100K+ to trigger stronger synchronous Ca2+ influx and then Forsklin, a 
supraphysiological pharmacological activator of Adenyly cyclase combined with IBMX a 
broad spectrum PDE inhibitor (Figure 2). At the onset of 100K+, there is a little to no 
increase in FRET ratios within the cell, and the same result is seen with the washing of 
Forsklin + IBMX in 100K+ (Figure 2). These results suggest that either resting MMQ 
cells do not have either Ca2+ (100 K+) or forskolin stimulated adenyl cyclase. An 
alternative explanation is that resting [cAMP] was sufficiently high to saturate the cAMP 
FRET reporter. The latter is likely given that the reporter was designed as a high affinity 
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reporter to detect physiological changes in [cAMP] (Stojilkovic, 1992)..  The latter also is 
likely in that forskolin is known to cause extremely high cAMP production in all cells. In 
order to further analyze the  [cAMP]c that in resting MMQ cells, a biochemical cAMP 
assay was performed. This assay lacks temporal resolution but is less sensitive and has a 
higher dynamic range. The results (Figure 3) demonstrate that resting (control) cells have 
a relatively low but detectable [cAMP]. When forskolin or IBMX were added to the cells, 
alone or in combination, [cAMP] increased dramatically. Therefore, [cAMP]c is high in 
resting MMQ cells, but still produced in increasing amounts with applications of cAMP 
stimulatory drugs.  Together the results of figure 2 and 3 indicate that in resting MMQ 
cells, [cAMP] was sufficiently high to saturate the FRET reporter but could clearly be 
increased by pharmacological activation of adenyl cyclase with forskolin and inhibition 
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Effects of physiological increase in cAMP on Ca2+ dynamics in MMQ cells 
  Peptides that activate GPCR that work via Gαs are known to increase prolactin 
secretion. Two such peptides are vasoactive intestinal polypeptide (VIP) and pituitary 
adenylate cyclase-activating peptide (PACAP). These peptides work on related but 
distinct receptors that trigger physiological increases in cAMP.  MMQ cells were imaged 
using Fura2 ratiometric [Ca2+] measurements.  VIP triggers an increase in intracellular 
calcium as evident by the increase in Ca2+ spikes (Figure 4.) Whereas PACAP works in a 
similar manner but at a much more delayed responses (Figure 5.) Therefore, 
physiologically, VIP and PACAP work to increasing intracellular [Ca2+]c, quite likely due 
to the well established cAMP-regulation of L-type Ca2+ channels. This represents 
crosstalk between cAMP and Ca2+ because VIP initially triggers an increase in [cAMP]c 
through the Gαs. The observation that VIP works more rapidly raises the possibility that 
these receptors may be clustered in closer proximity to Ca2+ channels than are PACAP 
receptors. 
PKA and EPAC regulation of Ca2+ dynamics in MMQ cells 
 In general, PKA and Epac are distinct cAMP targets in cells. Given that PKA is 
known to potentiate L-type Ca2+ channels in a wide variety of cell types, it is likely that 
the VIP/PACAP effects on Ca2+ in MMQ cells (Fig 4, 5) are due to activation of PKA.
 This was tested by comparing the ability of membrane permanent analogs of 
cAMP to activate either PKA (6Benz-cAMP) or Epac (cpt-cAMP) with high selectivity. 
Forsklin  a pharmacological activator of adenylate cyclase that increases cAMP levels 
much higher than would physiological receptor activation leads to robust increase in Ca2+ 
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spikes (Figure 6) . The forskolin response is stronger than the VIP/PACAP response 
(Figure 6 compare to 4 and 5). This forskolin result puts an upper limit on effects of 
cAMP on Ca2+ influx.  
Pharmacologically, 6-Benz-cAMP works through a PKA mediated pathway in 
which [cAMP]c increases. 6-Benz-cAMP has a delayed effect but once triggered, calcium 
influx is sustained (Figure 7). This is consistent with a slow PKA dependent potentiation 
of L-type Ca2+ channels. Cpt-cAMP initiates the Epac mediated pathway.  Cpt-cAMP had 
an immediate effect on calcium influx (figure 8) and a higher amplitude of spikes than 6-
Benz-cAMP had. This suggests that in addition to a well established effect of PKA on L-
type channels, that Epac can also potentiate Ca2+ influx. The Epac target could be a 
positive effect on the Ca2+ channel or an inhibitory effect on a K+ channel leading to 
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Inhibition of PDE activity increases cellular Ca2+ influx in MMQ cells  
              It is known that phosphodiesterases regulate cAMP signaling by degrading 
cAMP to AMP.  PDE’s are often anchored in specific location in cells and PDE isoforms 
often display unique subcellular localization from each other. Effects of the broad-
spectrum, non-selective PDE inhibitor, IBMX; the effect of a PDE3 inhibitor 
(Milironone) and a PDE4 inhibitor (Rolipram) on Ca2+ in MMQ was assessed. When 
IBMX was applied to cells, there was immediate calcium influx and sustained calcium 
influx throughout the duration of time (Figure 9). Perfusion of Milironone had a delayed 
response on increasing calcium, but high spiking occurred after inhibition of PDE3 
(Figure 10). The delayed response of Ca2+ influx in the cells suggests PDE3 may be 
located farther away from a calcium channel but once it triggers inhibition of PDE3, it 
has a strong/sustained effect on the calcium channel. Application of Rolipram to the 
MMQ cells had an immediate calcium response and is sustained throughout the duration 
of time. The data suggests that PDE4 maybe located closer to the calcium channel due to 
the immediate response to calcium influx (Figure 11).  
Cross talk with cAMP and Ca2+ in Alpha cells 
 The main source for Ca2+ in alpha cells comes from calcium induced calcium 
release. From previous work in the lab with alpha cells we know that increasing [cAMP]c 
in resting cells will in turn trigger calcium induced calcium release from the endoplasmic 
reticulum. This was demonstrated with both physiogical activation of adenylate cyclase 
by α-MSH  and by the PKA and Epac selective cAMP analogs in cells in 8 mM glucose, 
a concentration at which Ca2+ influx and glucagon secretion is minimal (“resting”). In 
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addition, acute hypoglycemia attained by switching from 8 to 2 mM glucsose triggered 
CICR. The studies on alpha cells for this thesis focused on the potential role of PDEs in 
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Alpha MSH and PDE interactions 
 Previous data has shown that α-MSH   induced a Gαs protein coupled response to 
increase calcium induced calcium release in alpha cells. Calcium imaging of alpha cells 
with α-MSH   has also shown that CICR pathway is stimulated with the binding of alpha 
MSH  (Liang, Masters Thesis, 2009).  In order to understand the relationship of  [cAMP]c 
levels and α-MSH, FRET-analysis of α-MSH  without any PDE inhibitor was tested.  
Strikingly, α-MSH  without any PDE on alpha cells produced no detectable cAMP 
response (Figure 17). This suggests that [cAMP]c is increasing in a microdomain where it 
can affect Ca2+ influx but a PDE is degrading cAMP before it can be detected by the 
FRET-reporter. α-MSH  with IBMX created an increase in [cAMP]c ( Figure 18). 
Milironone was present with aMSH and [cAMP]c increased at a slight slope (figure19). 
PDE3 must be close enough to the Gαs/cAMP motif to increase [cAMP]c before PDE3 
can degrade it. Rolipram has a better effect on increasing [cAMP]c than Milironone, 
suggesting PDE4 is even closer to the Gαs/cAMP motif to have [cAMP]c increase more 
than it can be degraded (Figure 20). However it should be noted that the effect on cAMP 
of α-MSH  + PDE inhibitor (figures 18, 19, 20) are similar to the respective PDE 
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Effect of PDE inhibitors hypoglycemia response in Alpha Cells 
 Alpha cells contain both N-type calcium channels and L-type calcium channels. 
During accute hypoglycemia within alpha cells, N-type and L-type channels are tightly 
regulated to allow influx of calcium. First  the Ca2+ response in a control plate was run 
with 8mM glucose washing over the plate for 5minutes followed by mimicking a state of 
hypoglycemia with 2mM glucose (Figure 21). This result is consistent with 
hypoglycemia induced CICR reported previously (Liang MS Thesis).  Milironone in 
2mM glucose showed a quick increase in slope and then an exaggerated initial response. 
This suggests cAMP produced by inhibiting PDE3 potentiated calcium influx and then 
was followed by normal store release within the cell (Figure 22). Rolipram in 2mM 
glucose showed a steady increase in calcium increase but without the quick calcium 
influx as PDE3 inhibitor did and the onset and slope of the response in the presence of 
rolipram was delayed/slower than control (Figure 23). These data suggest PDE3 and 
PDE4 have distinct roles in shaping signaling in alpha cells. 
Fret- analysis with PDE inhibitor in 2mM glucose  
 Previous FRET-cAMP analysis of the effect of hypoglycemia on [cAMP]c 
detected no increase in cAMP within the cell (Liang MS thesis). With that in mind, the 
effect of hypoglycemic state on [cAMP] was investigated using the three PDE inhibitors. 
[cAMP]c increases in a state of steady 2mM glucose with forsklin + IBMX and without 
the prescence of any PDE inhibitors (figure 24) .With the inclusion of IBMX (Figure 25), 
Milironone (Figure 26) and Rolipram (Figure 27) during hypoglycemia all [cAMP]c 
increased to an extent.  

















































 This project combined intracellular [Ca2+] imaging; Fret-analysis and a 
biochemical assay in order to understand the interactions between cAMP and Calcium for 
store release. MMQ cells and Alpha cells were investigated in this thesis. The data of 
MMQ cells concluded that [cAMP]c was high in the resting state of MMQ cells. 
Physiological and pharmacological pathways were induced in MMQ cells to understand 
the path in which calcium influx is initiated. Calcium imaging with PAC-AP, VIP and 
forskolin all proved a physiological way to increase calcium influx. PAC-AP and VIP 
triggered a Gαs pathway for calcium influx. The data supported VIP to be a more 
efficient physiological response for intracellular [Ca2+]c increase. Knowing that Gαs 
pathways will directly increase [cAMP]c then we can make the conclusion that cross-talk 
between an increase in [cAMP]c and Ca2+ must be occurring in MMQ cells. Forskolin is a 
stimulatory drug used on MMQ cells to increase adenylyl cyclase activity in the cells. 
Adenylyl cyclase coupled with ATP will stimulate cAMP production.  Calcium imaging 
with Forskolin increased [Ca2+]c, therefore forskolin provided more evidence for cAMP 
and calcium cross-talk in these cells.  
Pharmacologically, high concentrated drugs such as 6-Benz-cAMP analog and 8-
cpt-cAMP were used to induce calcium influx into MMQ cells. 6-Benz-cAMP is a known 
drug to trigger a PKA mediated pathway for store release. PKA is activated with cAMP 
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and since the data showed 6-Benz-cAMP to have increased [Ca2+] levels, then cross-talk 
between cAMP and Ca2+ can be inferred. 8-cpt-cAMP was the second pharmacological 
drug used to determine Ca2+ influx in MMQ cells. 8-cpt-cAMP is a drug that initiates an 
Epac independent pathway. From the data, the Epac pathway initiated a strong Calcium 
influx in MMQ cells, suggesting that Epac is a strong molecular target for cAMP. We can 
hypothesize that Epac is directly interacting with the L-type calcium channel and possibly 
has interactions with the Potassium channels on the plasma membrane, considering the 
strong calcium influx that 8-cpt-cAMP initiated.   
 Previous data from undergraduate research has identified three PDE inhibitors 
located near L-type voltage gated channels. The three PDE inhibitors were used on MMQ 
cells to monitor calcium levels within the cells. Knowing already that [cAMP]c is high in 
these cells, calcium imaging was used to discover how calcium influx is effected when  
PDEs are inhibited. IBMX being a non-selective PDE inhibitor, increased intracellular 
[Ca2+]c by inhibiting all PDEs and in turn inhibiting the degradation of cAMP throughout 
the entire cell. Milironone’s effect on MMQ cells suggested the location of PDE3 within 
the cell. The delayed reaction for intracellular [Ca2+]c suggests that PDE3 is located 
further away from a L-type calcium channel, but extremely effective at increasing 
intracellular [Ca2+]c once PDE3 is inhibited. The data showing Rolipram’s role on MMQ 
cells suggests a close interaction between PDE4 and L-type calcium channels because 
intracellular [Ca2+]c increased as cAMP degradation decreased.  
 Euglycemia in Alpha cells is represented by 8mM glucose extracellular solutions. 
Keeping consistent with the three PDE inhibitors used in MMQ cells, the same three 
inhibitors were used in Alpha cells for Fret- analysis and calcium imaging. The three 
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PDE inhibitors were used on alpha cells to determine relative [cAMP]c. IBMX and 
Milironone increased [cAMP]c within the cell. IBMX is consistent with what would be 
expected for Alpha cells. If all PDEs are inhibited throughout the cell there should be a 
noticeable increase in [cAMP]c. Milironone had an immediate and direct increase in 
[cAMP]c suggesting the location of PDE3 to be close to the calcium channels. Rolipram 
increased [cAMP]c as well. Therefore, PDE inhibitors were able increase [cAMP]c.  
Previous data in Alpha cells have shown that 2mM glucose induces CICR. In 
2mM glucose, Milironone showed a quick burst of calcium influx and then a sustained 
calcium influx, suggesting immediate calcium burst through the L-type voltage gated 
channel and N-type calcium channel and then sustained CICR. Rolipram showed less of a 
degree of a quick burst of calcium but still CICR was observed. Rolipram’s data suggests 
that Rolipram may be acting as an inhibitor of calcium influx.  The data between these 
PDE inhibitors suggests cross-talk between cAMP and calcium influx through the voltage 
gated channel. Combining the data between calcium imaging and Fret-analysis, 
Milironone was able to increase [cAMP]c efficiently as well as increase [Ca2+]c to the 
same degree, supporting the interaction between cAMP and calcium.  
Previous data has shown that alpha MSH induces a Gαs protein coupled response 
to increase calcium induced calcium release in alpha cells. Calcium imaging of alpha 
cells with Alpha MSH has also shown that CICR pathway is stimulated with the binding 
of alpha MSH and intracellular [Ca2+] increases  (Liang, Masters Thesis, 2009).  The next 
step is to investigate if [cAMP]c increases in the same manner [Ca2+]c did thus supporting 
cross-talk between the two. Fret-analysis of Alpha MSH without one of the three PDE 
inhibitor was tested first.  Alpha MSH without any PDE inhibitor produced no response. 
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This suggests that cAMP in the cell is degraded by a PDE inhibitor before cAMP can 
reach an indicator for detection. When Alpha MSH was diluted with IBMX there was a 
clear increase in global [cAMP]c. The Gαs pathway increases [cAMP]c and since all 
PDEs are inhibited, cAMP is able to be detected over time. Alpha MSH diluted with 
Milironone showed a much less severe slope suggesting more overall degradation of 
cAMP was occurring. The data showed Rolipram to increase [cAMP]c as well. The Fret-
analysis confirmed interactions between cAMP and Ca2+ since both were seen in 
increasing concentrations in Fret-analysis and calcium imaging. When alpha-MSH was 
shown without a PDE inhibitor and no cAMP was produced proves that the calcium 
channels and PDEs are located within a microdomain.  
Summary 
Both the calcium imaging and Fret-analysis confirmed that the three PDEs 
investigated in this thesis must be located near the plasma membrane because as 
intracellular  [cAMP]c increased through PDE inhibitors, voltage-gated channels [Ca2+]c  
as  well. These interactions must be working within a micro-domain.  
Future directions 
Although many questions regarding the interactions between cAMP and calcium 
were answered there are still questions to be answered.  The micro-domain in which 
cAMP and calcium work to increase store release is just a small aspect to many signaling 
pathways involved within cells. In this thesis, PDE inhibitors were used to confirm close 
cAMP production and calcium influx through voltage gated channels. Previous data of   
specifically located PDEs (Emily, Joseph Angleson undergraduate honors thesis) were 
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shown but further investigation of other PDEs isoforms within the cells by using 
inhibitors would help to clarify the role of other PDEs and possibly open the door to other 
specific pharmacological drugs.  
Another aspect to investigate would be the specific anchoring mechanisms of 
PDEs, either scaffolding proteins or allosteric binding sites. Understanding the 
mechanisms behind anchoring these PDEs can help further understand their enzymatic 
activities. PKAs were also shown in this thesis to initiate many pathways for cAMP 
production. Understanding the role of PKA involvement to AKAPS would expand our 
knowledge of regulating cAMP production. Once cAMP production can be controlled, 
this can be used universally for many different cells types. Specifically in Alpha cells a 
biochemical assay run for [cAMP]c levels will increase our understanding of resting 
[cAMP]c levels. Resting and elevated levels of [cAMP]c will guide the understanding of 
cAMP dominance for store release or CICR.  
PDE4 is known to have a specific interaction with the AKAPs that PKA targets, 
therefore if further investigation of the interaction of AKAPs with PKAs and then with 
PDEs would be researched then the role of PDEs could be better understood too. Also, 
inhibiton of PKAs can be a source of information for a direct pathway for decreasing 
[cAMP]c. 
Since Ryanodine receptors are known to be sensitive to calcium influx and thus 
induce calcium store release. The use of inhibitors on either IP3R or RyR could help to 
understand the direct roles of CICR.  
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Glucose levels are especially important in type I and type II diabetes. From a 
pharmacological point of view, as PDE inhibitors have been shown to be directly related 
to calcium influx and thus store release, specific drugs targeting PDE3 and PDE4 could 
be used in clinical trials to try to induce more store release of glucagon and insulin from 
pancreatic cells. Regulation of the cAMP and calcium interactions is an important 
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